These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 3527723

  • 1. Differential protracted effects of morphine and ethylketocyclazocine challenges on EEG and behavior in the rat.
    Young GA, Khazan N.
    Eur J Pharmacol; 1986 Jun 17; 125(2):265-71. PubMed ID: 3527723
    [Abstract] [Full Text] [Related]

  • 2. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat.
    Young GA, Khazan N.
    Neuropharmacology; 1984 May 17; 23(5):505-9. PubMed ID: 6330605
    [Abstract] [Full Text] [Related]

  • 3. Bidirectional cross-tolerance between methadone (mu)- and ethylketocyclazocine (kappa)-tolerant rats.
    Hong O, Young GA, Khazan N.
    Drug Alcohol Depend; 1986 Sep 17; 18(1):87-96. PubMed ID: 2877838
    [Abstract] [Full Text] [Related]

  • 4. Differential cross-tolerance among morphine, methadone, and ethylketocyclazocine--EEG and behavior.
    Hong O, Young G, Khazan N.
    NIDA Res Monogr; 1986 Sep 17; 67():170-6. PubMed ID: 2875392
    [No Abstract] [Full Text] [Related]

  • 5. EEG and behavioral effects of ethylketocyclazocine, morphine and cyclazocine in rats: differential sensitivities towards naloxone.
    Tortella FC, Cowan A, Adler MW.
    Neuropharmacology; 1980 Sep 17; 19(9):845-50. PubMed ID: 6106909
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of abstinence syndromes following chronic administration of mu and kappa opioid agonists in the rat.
    Young GA, Khazan N.
    Pharmacol Biochem Behav; 1985 Sep 17; 23(3):457-60. PubMed ID: 2996029
    [Abstract] [Full Text] [Related]

  • 7. Differential tolerance and cross-tolerance to chronic treatment with mu and kappa opioid agonists in the rat.
    Young GA, Khazan N.
    NIDA Res Monogr; 1984 Mar 17; 49():121-7. PubMed ID: 6090915
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
    Hong O, Young GA, Khazan N.
    Neuropharmacology; 1988 Aug 17; 27(8):807-12. PubMed ID: 2905786
    [Abstract] [Full Text] [Related]

  • 10. Self-administration of ketocyclazocine and ethylketocyclazocine by the rat.
    Young GA, Khazan N.
    Pharmacol Biochem Behav; 1983 Oct 17; 19(4):711-3. PubMed ID: 6359177
    [Abstract] [Full Text] [Related]

  • 11. Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.
    Gwynn GJ, Domino EF.
    J Pharmacol Exp Ther; 1984 Nov 17; 231(2):306-11. PubMed ID: 6092613
    [Abstract] [Full Text] [Related]

  • 12. EEG, EEG power spectral, and behavioral differences in response to acute ethylketocyclazocine administration in two inbred rat strains.
    Mayo-Michelson L, Young GA.
    Brain Res Bull; 1993 Nov 17; 31(3-4):345-51. PubMed ID: 8387865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN, Ramarao P, Gulati A.
    Eur J Pharmacol; 1989 Mar 21; 162(2):257-64. PubMed ID: 2542058
    [Abstract] [Full Text] [Related]

  • 16. Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: II. Morphine dependence.
    Haberny KA, Young GA.
    Eur J Pharmacol; 1994 Aug 11; 261(1-2):11-6. PubMed ID: 8001632
    [Abstract] [Full Text] [Related]

  • 17. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM.
    J Pharmacol Exp Ther; 1985 Jun 11; 233(3):863-9. PubMed ID: 2989500
    [Abstract] [Full Text] [Related]

  • 18. Tolerance and cross-tolerance studies with morphine and ethylketocyclazocine.
    Porreca F, Cowan A, Raffa RB, Tallarida RJ.
    J Pharm Pharmacol; 1982 Oct 11; 34(10):666-7. PubMed ID: 6128391
    [No Abstract] [Full Text] [Related]

  • 19. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.
    Slizgi GR, Ludens JH.
    J Pharmacol Exp Ther; 1982 Mar 11; 220(3):585-91. PubMed ID: 6121047
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.